Novelix Pharmaceuticals

quarterly
yearly
ParticularsSep '21Dec '21Mar '22Jun '22Sep '22
Revenue2.761.180.781.421.30
Expenses2.352.092.291.521.44
EBITDA0.040.04-0.030.020.02
EBIT0.44-0.95-1.48-0.09-0.15
Profit Before Tax0.44-0.95-1.48-0.09-0.15
Net Profit0.35-0.74-1.57-0.09-0.15
Financial Ratios
Operating Profit Margin19.11%-81.08%-218.84%-5.15%-10.48%
Net Profit Margin13.01%-55.86%-195.65%-5.15%-10.48%
Earning Per Share (Diluted)0.39-0.77-1.67-0.11-0.19
Dividends Per Share0.000.000.000.000.00